Get started
Work

Supplemental table S3 from The BTK Inhibitor Ibrutinib (PCI-32765) Overcomes Paclitaxel Resistance in ABCB1- and ABCC10-Overexpressing Cells and Tumors

Year: 2023
Type: supplementary-materials
Abstract: Ibrutinib does not significantly sensitizes ABCG2-overexpressing cells to mitoxantrone.
DOI: 10.1158/1535-7163.22503111.v1
Authors: Hui Zhang, Atish Patel, Yi-Jun Wang, Yun-Kai Zhang, Rishil J. Kathawala, Long-Hui Qiu, Bhargav A. Patel, Li-Hua Huang, Suneet Shukla, Dong-Hua Yang, Suresh V. Ambudkar, Li-Wu Fu, Zhe-Sheng Chen
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4362484824
Cites:
Cited by:
Related to: 10